Novo Nordisk on Monday announced a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the ...
Discover Magazine on MSN1d
New Drug Delivery System Could Reduce GLP-1 Shortage and Make It More EfficientLearn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback